Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects

Clinical Genetics

Volumn 55, Issue 3, 1999, Pages 160-172

  Comings, David E ^a   Gade Andavolu, Radhika ^a   Gonzalez, Nancy ^a   Blake, Hezekiah ^a   Wu, Shuijuan ^a   MacMurray, James P ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dyslexia; Learning disabilities; Noradrenergic

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; NORADRENALIN;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; GENETIC POLYMORPHISM; GILLES DE LA TOURETTE SYNDROME; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NORADRENALIN BLOOD LEVEL; NORADRENERGIC NERVE; PRESCHOOL CHILD; PRIORITY JOURNAL; READING; SCHOOL CHILD;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENES; GENOTYPE; HUMANS; LEARNING DISORDERS; MALE; MIDDLE AGED; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; REGRESSION ANALYSIS; TOURETTE SYNDROME;

EID: 0032896450     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.550304.x     Document Type: Article

References (77)

1. Aston-Jones G, Foote SL, Bloom FE. Anatomy and physiology of locus coeruleus neurons: functional implications. In: Ziegler MG, ed. Frontiers of Clinical Neuroscience, vol 2. Baltimore: Williams and Williams, 1984, pp. 92-116.
2. Mason ST. Noradrenaline and selective attention: a review of the model and the evidence. Life Sci 1980: 27: 617-631.
3. Dienstbier RA. Arousal and physiological toughness: implication for mental and physical health. Psychol Rev 1989: 96: 84-100.
4. Pliszka SR, Mccracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996: 35: 264-272.
5. Oades RD. Attention deficit disorder with hyperactivity (ADHD): the contribution of catecholaminergic activity. Prog Neurobiol 1987: 29: 365-391.
6. Shekim WO, Javaid J, Davis JM, Bylund DB. Urinary MHPG and HVA excretion in boys with attention deficit hyperactivity disorder and hyperactivity treated with D-amphetamine. Biol Psychiatry 1983: 18: 707-714.
7. Shekim WO, Dekirmenjian H, Chapel JL. Urinary MHPG excretion in minimal brain dsyfunction and its modification by D-amphetamine. Am J Psychiatry 1997: 136: 667-671.
8. Yu-cum S, Yu-feng W. Urinary 3-methoxy-4 hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome. Biol Psychiatry 1984: 19: 861-868.
9. Rapoport JL, Mickkelsen EJ, Ebert MH, Brown GL, Weise VL, Kopin IJ. Urinary catecholamine and amphetamine excretion in hyperactive and normal boys. J Nerv Ment Dis 1978: 66: 731-735.
10. Zametkin AJ, Karoum F, Linnoila M, Rapoport JL, Brown GL, Chuang LW, Wyatt RJ. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine. Arch Gen Psychiatry 1985: 42: 251-255.
11. Khan AU, Dekirmenjian H. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome. Am J Psychiatry 1981: 138: 108-112.
12. Hanna GL, Ornitz EM, Hariharan M. Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys. Biol Psychiatry 1996: 40: 553-555.
13. Klinteberg BA, Magnusson D. Aggressiveness and hyperactive behavior as related to adrenaline excretion. Special issue: personality and aggression. Eur J Personal 1989: 3: 81-93.
14. Pliszka SR, Maas JW, Rogeness GA, Baker J. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1994: 33: 1165-1173.
15. Girardi NL, Shaywitz SE, Shaywitz BA, Marchione K, Fleischman SJ, Jones TW, Tamborlane WV. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatr Res 1995: 38: 539-542.
16. Mefford IN, Potter WZ. A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation. Med Hypotheses 1989: 29: 33-42.
17. Shen Y-C, Wang Y-F. Urinary 3-methoxy-4-hydroxyphenyglycol sulfate excretion in seventy-three school children with minimal brain dysfunction and hyperkinesis. Biol Psychiatry 1984: 19: 861-871.
18. Shekim WO, Dekirmenjian H, Chapel JL. Urinary MHPG in minimal brain dysfunction and its modification by D-amphetamine. Am J Psychiatry 1979: 136: 667-671.
19. Donnelly M, Rapoport JL, Potter W, Oliver J, Keysor CS, Murphy DL. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Arch Gen Psychiatry 1989: 46: 205-212.
20. Posner MI, Peterson SE. The attention system of the human brain. Annu Rev Neurosci 1990: 13: 25-42.
21. Comings DE, Wu H, Chiu C, Ring RH, Dietz G, Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes-DRD2, DBH and DAT1. Am J Med Gen (Neuropsych Genet) 1996: 67: 264-288.
22. Halperin JM, Newcorn JH, Schwartz ST, McKay KE, Bedi G, Sharma V. Plasma catecholamine metabolites in ADHD boys with and without reading disabilities. J Clin Child Psychol 1993: 22: 219-225.
23. Halperin JM, Newcorn JH, Koda VH, Pick L, McKay KE, Knott P. Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. J Am Acad Child Adolesc Psychiatry 1997: 36: 1688-1696.
24. August GJ, Garfinkel BD. Behavioral and cognitive subtypes of ADHD. J Am Acad Child Adolesc Psychiatry 1989: 28: 739-748.
25. McGee R, Williams S, Moffitt T, Anderson J. A comparison of 13-year-old boys with attention deficit and/or reading disorder on neuropsychological measures. J Abnorm Child Psychol 1989: 17: 37-53.
26. Pennington BF, Groisser D, Welsh MC. Contrasting cognitive deficits in attention deficit hyperactivity disorder versus reading disability. Dev Psychol 1993: 29: 511-523.
27. Dykman RS, Ackerman PT, Oglesby DM. Selective and sustained attention in hyperactive learning disabled and normal boys. J Nerv Ment Dis 1979: 167: 288-297.
28. Richards GR, Samuels SJ, Turnure JE, Ysseldyke JE. Sustained and selective attention in children with learning disabilities. J Learn Disabil 1990: 23: 129-136.
29. Malone MA, Kershner JR, Swanson JM. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. J Child Neurol 1994: 9: 181-189.
30. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiat 1985: 24: 617-629.
31. Comings DE, Comings BG, Tacket T, Li S. The clonidine patch and behavioral problems. J Am Acad Child Adolesc Psychiatry 1990: 29: 667-668.
32. Starke K, Montel H, Gayk W, Marker R. Comparision of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 1974: 285: 133-150.
33. Arnsten AF, Steere JC, Hunt RD. The contribution of a,-noradrenergic mechanism to prefrontal cortical cognitive function. Potential significance for Attention-Deficit Hyperactivity Disorder. Arch Gen Psychiatry 1996: 53: 448-455.
34. Lario S, Calls J, Cases A, Orila J, Torras A, Rivera F. Msp 1 identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. Clin Genet 1997: 51: 129-130.
35. Riess O, Weber B, Hayden MR. (CA)n-dinucleotide repeat polymorphism at the locus for the alpha2C adrenergic receptor (ADRA2C) on 4q16. Hum Mol Genet 1992: 1: 452.
36. d'Amato T, Leboyer M, Malafosse A, Samolyk D, Lamouroux A, Junien C, Mallet J. Two Taq I dimorphic sites at the human β-hydroxylase locus. Nucleic Acids Res 1989: 17: 5871.
37. Wu S, Muhleman D, Comings DE. PCR amplification of the Taq I B1/B2 polymorphism at intron 5 of the dopamine β-hydroxylase gene. Psychiat Genet 1997: 7: 39-40.
38. Wei J, Ramchand CN, Hemmings GP. Possible control of dopamine β-hydroxylase via a codominant mechanism associated with polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 1997: 99: 52-55.
39. Comings DE. Polygenic inheritance and micro minisatellites. Mol Psychiatry 1998: 3: 21-31.
40. Riess O, Thies U, Siedlazck I, Potisek S, Graham R, Theilmann J, Grimm T, Epplen JT, Hayden MR. Precise mapping of the brain alpha 2-adrenergic receptor gene within chromosome 4p16. Genomics 1994: 19: 298-302.
41. Comings DE. Polygenetic inheritance of psychiatric disorders. In: Blum K, Noble EP, Sparks RS, Sheridan PJ, eds. Handbook of Psychiatric Genetics. Boca Raton, FL: CRC Press, 1996, pp. 235-260.
42. Plomin R, DeFries JC. The genetics of cognitive abilities and disabilities. Sci Am 1998: 278: 62-69.
43. Stevenson J. Evidence for a genetic etiology in hyperactivity. Behav Genet 1992: 22: 337-344.
44. Stevenson J, Pennington BF, Gilger JW, DeFries JC, Gillis JJ. Hyperactivity and spelling disability: testing for shared genetic aetiology. J Child Psychol Psychiatry 1993: 34: 1137-1152.
45. Sherman DK, McGure MK, Iacono WG. Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. Am J Psychiatry 1997: 154: 532-535.
46. Gillis JJ, Gigler JW, Pennington BF, DeFries JC. Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnorm Child Psychol 1992: 20: 343-348.
47. Hudziak JJ, Heah A. Reich W, Slutske W, Madden P, Bierut L, Bucholz K, Todd R. Latent class and genetic annalysis of DSM-IV attention-deficit/hyperactivity disorder. Am J Med Gen (Neuropsych Genet) 1997: 74: 567-568.
48. Sherman DK, Iacono WG, McGue MK. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997: 36: 745-753.
49. Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder with hyperactivity: are they genetically related. J Am Acad Child Psychiatry 1984: 23: 138-146.
50. Comings DE, Comings BG. Comorbid behavioral disorders. In: Kurlan R, ed. Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. New York: Marcel-Decker, 1993: 111-147
51. Comings DE. ADHD with Tourette syndrome or tic disorders. In: Brown TE, ed. Attention Deficit Disorders and Comorbidities in Children, Adolescents and Adults. Washington: Am Psychiat Press, 1998a (in press).
52. Comings DE. Tourette syndrome: a hereditary neuropsychiatric spectrum disorder. Ann Clin Psychiatry 1995: 6: 235-247.
53. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Chen C, Koh P, Farwell K, Blake H. Dietz G, Saucier G, MacMurray JP. A multiple additive associations technique for the identification of genes in polygenic disorders: results for ADHD and comorbid disorders in Tourette syndrome. 1998 (submitted).
54. Diagnostic and Statistical Manual of the American Psychiatric Association IV. Washington, DC: American Psychiatric Association, 1994.
55. Comings DE. Tourette Syndrome and Human Behavior. Duarte, CA: Hope Press, 1990.
56. Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987: 41: 701-741.
57. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse. Drug Alcohol Depend 1994: 35: 17-24.
58. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. Drug Alcohol Depend 1994: 35: 1-16.
59. Comings DE. The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their relatives. J Dev Behav Pediatr 1995: 16: 142-157.
60. Robins LN, Heizer J, Croughan J, Ratclif KS. National Institute of Health diagnostic interview schedule. Arch Gen Psychiatry 1981: 38: 381-389.
61. Sherrington R, Baljinder BS, Attwood J et al. A highly polymorphic microsatellite for the human dopamine (D5) receptor (DRD5) shows tight linkage to the chromosome 4p reference marker RAF1P1. Genomics 1994 (in press).
62. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, CHen C, Koh P, Farwell K, Blake H, Dietz G. MacMurray JP, Lesieur HR, Rugle LJ, Rosenthal RJ. The additive effect of neurotransmitter genes in pathological gambling. 1998b (submitted).
63. Brown TE. Brown Attention-Deficit Disorder Scales. San Antonio, TX: The Psychological Corporation Harcourt Brace and Co., 1996.
64. 2 tests. Biometrics 1954: 10: 417-454.
65. Silverstein F, Smith CB, Johnston MV. Effect of clonidine on platelet alpha 2-adrenoreceptors and plasma norepinephrine of children with Tourette syndrome. Dev Med Child Neurol 1985: 27: 793-799.
66. Arnsten AFT. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997: 11: 151-162.
67. Aoki C, Go C-G, Venkatesan C, Kurose H. Perikaryal and synaptic localization of alpha-2A-adrenergic receptor-like immunoreactivity. Brain Res 1994: 650: 181-204.
68. Goldman-Rakic PS. Topolography of cognition: parallel distributed networks in primate association cortex. Annu Rev Neurosci 1988: 11: 137-156.
69. Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL, Amrung SA, Harris WR. Clinical characteristics of emotionally disturbed boys with very low activities of dopamine-hydroxylase. J Am Acad Child Adolesc Psychiatry 1984: 23: 203-208.
70. Rogeness GA, Maas JW, Javòrs MA, Macedo CA, Fischer C, Harris WR. Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res 1989: 27: 241-251.
71. Isquierdo I, Beamish D, Anisman H. Effect of an inhibitor of dopamine-beta-hydroxylase on the acquisition and retention of four different avoidance tasks in mice. Psychopharmacology (Berlin) 1979: 63: 173-178.
72. Comings DE. Search for the Tourette Syndrome and Human Behavior Genes. Duarte, CA: Hope Press, 1996.
73. Comings DE. Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. Alcohol 1998: 16: 61-70.
74. Knell E, Comings DE. Tourette syndrome and attention deficit hyperactivity disorder: evidence for a genetic relationship. J Clin Psychiat 1993: 54: 331-337.
75. Comings DE, Comings BG. A controlled study of Tourette syndrome. I-VII. Am J Hum Genet 1987: 41: 701-866.
76. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiat 1990: 29: 526-533.
77. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993: 150: 1792-1798.